Log in
Enquire now
‌

US Patent 9624213 Compounds and methods for kinase modulation, and indications therefor

Patent 9624213 was granted and assigned to Plexxikon Inc. on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Plexxikon Inc.
Plexxikon Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96242130
Patent Inventor Names
Hanna Cho0
Todd Ewing0
Wayne Spevak0
Ying Zhang0
Chao Zhang0
Guoxian Wu0
Jack Lin0
Jiazhong Zhang0
...
Date of Patent
April 18, 2017
0
Patent Application Number
138207340
Date Filed
February 1, 2012
0
Patent Citations Received
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
Patent Primary Examiner
‌
San-Ming Hui
0
Patent abstract

Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9624213 Compounds and methods for kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.